<DOC>
	<DOC>NCT00319111</DOC>
	<brief_summary>The present trial investigates the long-term safety, tolerability and efficacy of bosentan in patients with inoperable CTEPH.</brief_summary>
	<brief_title>Bosentan in Patients With Inoperable Chronic Thromboembolic Pulmonary Hypertension (CTEPH)</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Hypertension, Pulmonary</mesh_term>
	<mesh_term>Bosentan</mesh_term>
	<criteria>Patients having completed the 16week treatment period of protocol AC052366 (NCT00313222) Signed informed consent Any major violation of protocol AC052366 (NCT00313222) Pregnancy or breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>November 2012</verification_date>
	<keyword>pulmonary hypertension</keyword>
	<keyword>bosentan</keyword>
	<keyword>BENEFIT</keyword>
	<keyword>CTEPH</keyword>
	<keyword>inoperable chronic thromboembolic pulmonary hypertension (CTEPH)</keyword>
</DOC>